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Abstract 
The human papillomavirus (HPV) is responsible for 99% of cervical cancers and many other 
cancers, including vulvar, vaginal, oropharyngeal, anal and penile. An HPV vaccine was 
introduced in the United States in 2006, and is now recommended for males and females nine to 
26 years of age. The vaccine has been shown to be both safe and efficacious. Despite this, HPV 
vaccination rates remain low in the United States. According to the Centers for Disease Control 
and Prevention only 60% of females and 56% of males age nine to 17 years old have initiated the 
two- to three-dose series. The purpose of this project was to evaluate parental intent to vaccinate 
and vaccine uptake in age-appropriate children who have not received the HPV vaccine after 
brief educational intervention on HPV and HPV vaccine. A county health department in the 
Midwest region of the United States was the site for this educational project with a convenience 
sample of 20 individuals. Two registered nurses were educated on the project and were given a 
script, which highlighted the key points of an educational pamphlet from the CDC on the HPV 
virus and vaccination to review with parents. The outcomes were evaluated using the same three 
questions pre- and post-test. By providing education about the human papillomavirus to parents 
and increasing awareness regarding the importance of vaccination, the author anticipated 
increased intent to vaccinate and improved vaccination uptake within the participants. The pre-
test indicated half of the parents surveyed believed HPV to be the most prevalent sexually 
transmitted infection, while the remainder did not believe it was the most common infection. 
Most parents did feel the vaccine was safe and effective. The same number of parents were 
planning on vaccinating their children against HPV. The post-test demonstrated slightly more 
parents believed that HPV was the most common disease after the educational intervention. After 
the educational intervention there was also a slight increase in parents that believed the vaccine 
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to be safe and planned on vaccinating their child. The author anticipated a more robust increase 
in both knowledge and intent to vaccinate after the educational intervention. In analyzing both 
the pre-test and post-test it appeared the majority of parents surveyed had knowledge of the 
vaccine and believed the vaccine to be safe prior to participating in the survey. Fewer parents 
were unaware that HPV is the most common sexually transmitted infection.  
Keywords: human papillomavirus, HPV, HPV vaccine, vaccine uptake, intent to vaccinate 
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Parental Education and HPV Vaccination Intent 
Statement of the Problem and Significance 
In 2006, the United States Food & Drug Administration (FDA) licensed the first vaccine 
aimed at preventing cervical cancer. Currently, cervical cancer is the third most frequently 
diagnosed gynecological cancer in the United States. Human papillomavirus (HPV) types 16 and 
18 are responsible for 70% of cervical cancers. Ninety-nine percent of cervical cancers are 
caused by persistent high-risk HPV infections. The HPV is also associated with other types of 
cancers, including: vulvar, vaginal, oropharyngeal, anal, and penile cancer (American Cancer 
Society [ACS], 2014). Healthy People 2020, national objectives for improving health of all 
Americans, set a goal of 80% of adolescent females age 9 to 15 years initiating the HPV vaccine 
series (U.S. Department of Health and Human Services, n.d.). 
The HPV vaccine has proven to be both safe and efficacious. Despite this, vaccination 
rates remain low in the United States and even lower in Kansas (Chilson, 2018). According to 
the Centers for Disease Control and Prevention (CDC, 2013), the completion rates for the HPV 
vaccine series were low with 32% of boys age 13- to 17-years-old, and 43% of girls 13- to 17-
years-old finishing the series. The statistics in Kansas demonstrated even lower completion rates. 
In Franklin and Miami counties (in northeast Kansas), 7% of all nine- to 18-year-old individuals 
have completed the two- to three-dose series. The rates are similar in the neighboring counties of 
Douglas and Johnson counties, where 8% of nine- to 18-year-old individuals have completed the 
series (Kansas Foundation for Medical Care, Inc., 2014). 
 According to the CDC (2013), the human papillomavirus is the most common sexually 
transmitted infection in the United States. The National Cancer Institute (NCI, 2012) estimates 
that over half of sexually active individuals will develop a HPV infection during their lifetime. 
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Approximately 99.7% of cervical cancers are caused by persistent high-risk HPV infections. 
There are fifteen known oncogenic, or cancer causing, types of the human papillomavirus, with 
types 16 and 18 accounting for 70% of cervical cancers. The economic burden of cervical cancer 
in the United States in 2010 was over eight billion dollars (NCI, 2012). Currently there are two 
HPV vaccines available in the United States. Both vaccines include protection from types 16 and 
18. By improving vaccine rates for the human papillomavirus, cervical cancer rates are predicted 
to significantly decrease, as would rates for other cancers caused by the virus in both males and 
females. 
Purpose Statement 
The economic burden for treating cervical cancer in the United States in 2010 was over 
eight billion dollars (NCI, 2012). Currently there are two vaccines available in the United States 
and all three include protection from types 16 and 18. By improving vaccine rates for HPV, 
cervical cancer rates are predicted to significantly decrease, as are the rates for other cancers 
caused by the virus in both males and females. 
The project PICO question: “Does education of parents of adolescents age 9 to 17 years 
about the human papillomavirus and HPV vaccination increase the intent to vaccinate their 
children against HPV compared to those parents who have not received the educational 
intervention?” Parents of adolescents, both males and females, age 9 to 17 years were targeted, 
as children under 18 years old require parental consent for vaccination. 
The purpose of this project is to increase HPV vaccine intent in parents of age-
appropriate children that have not received the HPV vaccine and increased uptake of the vaccine 
for those children. A brief educational intervention for parents on HPV and the HPV 
immunization will increase knowledge. Parents of children age 9-17 that are unvaccinated 
 6 
against HPV would be identified at the Franklin County Health Department when seeking 
mandatory immunizations required by the educational system. A brief, three-question pretest 
would be given, followed by receiving the educational pamphlet from the CDC, HPV Vaccine 
for Preteens and Teens. A registered nurse would review the key components of the pamphlet 
with the parent using a provided script. The same three-question test would be administered post-
intervention to evaluate change in knowledge and intent to vaccinate. This project was a small 
pilot project within Franklin County, Kansas, where HPV vaccine rates are among the lowest in 
the state. The project was an educational intervention that established an evidenced-based 
protocol to improve intent to vaccinate. 
      If this pilot project was successful in improving intent to vaccinate and vaccine uptake, 
the educational intervention could be broadened as routine protocol within the county’s health 
department and shared with other health departments within the state. The ultimate, long-term 
goal of the project would be increased vaccine uptake rates within the county. Decreasing the 
incidence of HPV infection and sequelae would improve the overall health of the population, and 
decrease the economic burden on the community it was, with costs including: copying or 
reproducing the educational pamphlet provided by the CDC, and minimal time and cost to 
educate staff.  It would be low cost. The project may be easily reproducible for other public and 
private clinics. 
Concepts and Variables 
The Health Belief Model guided this project. Croyle (2005) describes the Health Belief 
Model as assessing a health-related concern and identifying a need for change in that health 
behavior (See Figure 1).  Once the need is assessed and risks of not changing the pattern of 
behavior are identified, this information is communicated to the targeted population along with 
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steps recommended to change behavior. The health care provider identifies any barriers to 
change and assists with removing or reducing the perceived barriers. The health care provider 
assists by providing skill development and support. Through this process, self-efficacy is 
improved, thereby increasing the likelihood of successful change.            
 
Figure 1. Health Belief Model. Adapted from Croyle, R.T. (2005). Theory at a Glance:  
Application to Health Promotion and Health Behavior,2nd edition. U.S. Department of Health & 
Human Services:  Washington, D.C. 
                                                                                                               
Utilizing the Health Belief Model, parents were educated about their child’s susceptibility 
to HPV, the severity and consequences of HPV infection, the benefits of vaccine uptake, and 
relatively low cost of the vaccine which was predicted to improve vaccine uptake. Assistance 
was provided by answering questions, providing information about programs to assist with 
payment for vaccine if their child was not insured and having the vaccine immediately available 
if immunization requested at time of study. These steps lowered barriers to vaccine uptake.                                                                                                                             
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Concepts and variables of interest include parental education and intent to vaccinate. 
Education of parents was provided by both a written brochure reinforced with a scripted review 
of key highlights of the review. Intent to vaccinate was assessed before and after the educational 
intervention. Outcome concepts were intent to vaccinate following the educational     
intervention. The operational measurement of the concepts would include improved scores 
following the educational intervention, measured by increased intent to vaccinate within Franklin 
County, Kansas. 
Literature Review 
Overview of Literature Search 
A comprehensive literature review was performed using PubMed, CINAHL® and the 
Cochrane Database of Systematic Reviews. A search of keywords included: “parental 
education”, “educational intervention”, “HPV vaccination”, “HPV vaccination initiation”, and 
“paternalistic decision-making”. Articles were limited to those written in English and published 
in the past five years. All educational interventions were included. Articles excluded were those 
with educational interventions for patient 18 years of age and older. 
Review and Synthesis of Articles 
After reviewing the current literature, several themes resonate, which include the 
following: 
1) The educational needs of parents, adolescents and health care providers must be
addressed;
2) Adolescent decision-making should be reviewed and included in prescribed
interventions;
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3) Health care providers should be forth coming with information about HPV infection and 
vaccination; and  
4) A variety of educational interventions could be employed to increase intent to vaccinate 
and actual vaccine uptake. 
The themes will now be reviewed with more depth to provide understanding and background for 
this project.  
Educational Needs 
Kester, Sheed-Steele, Dotson-Roberts, Smith, and Zimet (2014) and Kowalczyk et al. 
(2013) found a need to increase awareness of HPV disease, including transmission, prevalence, 
and consequences of HPV infection, among adolescents and parents. Kowalczyk Mullins, et al. 
(2013) also cited a need for education on vaccine safety and efficacy. Hendry et al. (2013) came 
to the same conclusion regarding lack of knowledge regarding HPV and vaccine, but went on 
further to conclude that this lack of knowledge was so poor that it impeded the parent’s ability to 
make informed choices about vaccination and ultimately impacted cervical cancer screening 
behaviors. Holman, Bernard, Roland, Liddon, and Stokley (2014) performed a systematic review 
to assess knowledge and barriers to HPV vaccine uptake. In the review, parents cited lack of 
information, concerns about vaccine safety and efficacy and low perceived risk of HPV infection 
as reasons to decline vaccination.  
Three additional articles (Guerry et al., 2011; Allen, Othus, & Shelton, 2010; & Spleen, 
Kushman, Lark, Digman, & Lengerich, 2012) also cited a profound need to educate adolescents, 
parents and health care providers on HPV disease as well as HPV vaccine safety and efficacy. 
Allen et al. (2010) identified a need to explore educational needs among different ethnic groups 
and possibly target educational strategies differently to among ethnic subgroups.  
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Adolescent Decision-Making 
Kowalczyk Mullins et al. (2013) conducted 33 interviews with adolescent girls age 11-12 
years old and their adult, female primary caregiver. The study identified that parents are an 
important source of information for girls; therefore, clinicians need to provide parents with 
education focused on HPV disease and prevention while encouraging parents to engage in 
discussions about this topic with their children. Guerry et al. (2011) and Allen et al. (2010) 
conducted surveys to assess knowledge regarding HPV disease and vaccine. Both groups found 
adolescents with very limited knowledge of HPV and HPV vaccine. The authors also identified 
parents as an important information source for adolescents and recommended targeting education 
to parents, so the parents would be equipped to address adolescent concerns and questions about 
HPV disease and vaccine. Kester et al. (2014) performed a randomized survey of 131 young 
adults and concluded that there continued to be a low awareness of HPV disease and vaccine 
benefits. 
Emotions and peer reaction play an important role in adolescent decision making 
(Blakemore & Robbins, 2012; Chang et al., 2018; Grandahl et al., 2018). Factors such as fear of 
needles and fear of pain should be addressed when counseling adolescents regarding HPV 
vaccination. Chang et al. (2018) addressed the need for teens to participate in the decision 
making for HPV vaccination, citing the importance of autonomy for adolescents.  
Health Care Provider Recommendations 
Parents consistently report health care provider recommendations as the most important 
factor in the decision to vaccinate against HPV (Guerry & DeRosa, 2011; Holman et al., 2014; 
Thavarajah, Chow, & Arocha, 2015; Dorell, Yankey, Kennedy, & Stokley, 2013; Trim, Naushin, 
Elit, & Roy, 2012; Allen et al., 2012).  Provider trust and positive attitude when presenting 
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information regarding the HPV vaccination were also identified as important (Tharavarajah et 
al., 2015). In contrast, Spleen et al. (2012) and Javanbakht et al. (2012) recommended a 
community-based approach to intervention citing that community stakeholders are committed to 
prevention of a disease that disparately affects their community. Javanbakht et al. (2012) 
identified the preferred information source for parents was a peer and recommended 
interventions that incorporated the use of “promotaras” or peer liaisons between health 
organizations and the community. These same investigators identified a need for more research 
targeting a variety of ethnic and culturally diverse groups.  
Educational Interventions to Increase Vaccine Uptake 
The information provided to both adolescents and their parents must be balanced, clear 
and concise (Wegwarth, Kurzenhauser-Carstens, & Gigerenzer, 2014). Parents must be educated 
not only regarding HPV and vaccine, but also on how to engage in discussions about these topics 
with their children (Kowalczyk et al., 2013).  A variety of interventions have been researched 
including mother-daughter dyads (Winer et al., 2016), programs focused on provider education 
promote the HPV vaccination (Fuller, 2017), and designing interventions based on domains of 
interest (Foley et al., 2015). The educational interventions employed did improve vaccine uptake 
in these studies. Fu, Bonhomme, Cooper, Joseph & Zimet (2014) performed a systematic review 
on educational interventions to increase HPV vaccination acceptance. The authors found that 
although educational interventions did improve vaccine acceptance and uptake, there was not 
strong evidence to recommend any one specific intervention.   
Conclusion 
There are many consistencies in the literature reviewed regarding HPV vaccination and 
decision-making. It is apparent through the literature review that there is a need for ongoing 
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education for parents, adolescents and health care providers on HPV infection and vaccine safety 
and efficacy. Parents gain most of their information regarding HPV from both their health care 
provider and peers in the community. Adolescents, in contrast, receive their information 
regarding HPV from their parents. Education provided must be clear and concise as it has a 
trickle-down effect. Health care providers must have and provide accurate information to parents 
so that parents can provide accurate information to their children and peers in the community. 
The key to accurate information and understanding of the HPV infection and HPV vaccine is 
education. 
The current literature has focused primarily on barriers to HPV vaccine uptake, especially 
educational barriers. Fewer articles evaluated specific educational interventions for parents and 
adolescents that are effective in promoting HPV vaccine uptake. There is a definite need for 
additional research on specific educational interventions and their effectiveness in promoting 
HPV vaccination uptake and overall HPV knowledge. Research on effective educational 
interventions would hopefully identify specific interventions that could be promoted universally. 
Additionally, research needs to be conducted targeting a variety of ethnic and culturally diverse 
groups. The majority of the current literature focuses on vaccination of females, but research is 
needed that includes interventions with males. 
Methods 
Approach 
The purpose of the project was to increase parental knowledge of HPV and the HPV 
vaccine to increase intent to vaccinate and actual HPV vaccine uptake, thus improving patient 
outcomes by impacting the numbers of individuals immune to the HPV virus. The project aimed 
to improve the HPV vaccination process within the county health department by intervening with 
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a brief educational tool. The project was evaluated by the Human Subjects Committee and 
received expedited status as an educational intervention.  
The steps within the project included the following: (1) identify a concern, need, or 
opportunity; (2) assess for need or opportunity; (3) plan development; (4) execute project; and 
(5) assess to see if improvements are needed. In the case of this project, the concern was low 
HPV vaccination rates. The second step was assessing for need or opportunity. The opportunity 
identified for the project was the opportunity to provide education to parents already at the 
county health department with their children for school-required immunizations. Next, a plan 
was developed to provide an educational pamphlet and provide additional information through a 
script highlighting key points of the pamphlet. Finally, the project was executed and assessed to 
see if improvements are needed.  
Author’s Assumptions 
For this project, the author assumed that increased parental knowledge regarding HPV 
would result in increased desire for the parents to vaccinate their children. An assumption for 
improved outcomes in healthcare is that health care providers are willing and have the desire to 
educate their clients. In this project, the author assumed that the nurses providing the educational 
intervention have the desire to increase the client’s knowledge. Another assumption of the 
project is that the parents want to be more educated regarding HPV and the vaccine. Healthcare 
improvement assumes that making a change in the delivery process, such as providing education, 
will result in improved patient outcomes, such as improved vaccination rates. 
Project Design 
This project included an educational intervention. The design for the project was to 
provide a script to the registered nurses working at a local health department highlighting key 
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points of the CDC pamphlet, HPV Vaccine for Preteens and Teens (CDC, 2013). This pamphlet, 
which is an evidenced-based one-page pamphlet, described the following:  a) importance of 
vaccination, b) when children should be vaccinated, c) why children should get the HPV vaccine, 
d) safety and efficacy of the vaccine and e) possible side effects. The pamphlet also discussed the 
Vaccines for Children program and where a parent could get more information regarding the 
program. The parents would be given a three-question pretest while waiting to be taken back to 
the room. Once in the room, the registered nurse read the highlights of the pamphlet to the 
parent. The script was directly from the pamphlet itself, reinforcing information contained within 
it. The parents were then given the same three questions as a posttest and given an opportunity to 
have the HPV vaccine given to their child in addition to the vaccines for which they presented. 
The pre- and posttests were collected and evaluated for knowledge improvement and the impact 
of the educational intervention on the intent to vaccinate. The project design is simple and 
straightforward; therefore, the project could be easily replicated in other public and private health 
care facilities. The number of subjects was chosen to keep the pilot project achievable in a one-
month time frame, yet provide adequate information regarding the results. 
 Project Sample 
The population sample was from Franklin County, Kansas, which has a population of 
25,740 (US Census Bureau, 2013). More specifically, the sample was pulled from the Franklin 
County Health Department located in Ottawa, Kansas, population 12,482 (US Census Bureau, 
2013). The Franklin County Health Department is the only location within the county that 
provides vaccinations. 
The project sample included twenty parents of children ages nine to 17 years who have 
not received the HPV vaccination. The parents presented with their child(ren) to the health 
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department for routine school-required vaccines, which routinely included DTap and 
meningococcal vaccinations for children between eleven and twelve years of age. 
Data Collection Methods 
A three-question pretest (see Appendix A) was administered followed by a brief scripted 
educational intervention by a Registered Nurse highlighting key points of an educational 
brochure. The same three-question posttest (see Appendix B) followed the brief educational 
intervention. Both the pretest and posttest were printed on paper and contained “yes/no” 
questions. The questions were based on teaching/learning objectives and parental intent to 
vaccinate. The questions for the pre- and posttest and the CDC brochure, HPV Vaccine for 
Preteens and Teens, were reviewed by a doctorally-prepared faculty member at the University of 
Kansas School of Nursing with expertise in women’s health, midwifery, and family medicine. 
Demographic data collected was minimal, only identifying an age range and gender of the 
parent.  
Human Subjects Protection 
This project was designated as an exempt study by the University of Kansas Medical 
Center Institutional Review Board/Human Subjects Committee. Participants were recruited for 
inclusion in the study and signed a consent form prior to participation (see Appendix C). Results 
of the surveys were not linked to the signed consent forms.   
Procedure 
The full-time Registered Nurses (RNs) at the Franklin County Health Department were 
provided education regarding the project, purpose, and objectives by the project director in a 
twenty-minute presentation the week prior to initiation of the project. The RNs were given a 
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script to present to parents highlighting the key points of an educational brochure from the CDC 
entitled HPV Vaccine for Preteens and Teens (see Appendix D). 
When parents of age-appropriate children who had not received the HPV, vaccine arrived 
at the health department for other school-required vaccines, the receptionist asked if they were 
willing to participate in the study. The receptionist provided the parent with the consent form, 
pre-test, and the educational pamphlet. The parents completed the consent form and the pre-test 
in the waiting room while waiting to be called back to the immunization room.  
While in the immunization room, the RN collected the completed consent form. The RN 
then reviewed the highlights of the pamphlet from a script and had the parent complete the 
identical posttest. The RN collected the pre-test and posttests from the parent and placed the tests 
in a collection box located in the room. The RN then offered the HPV vaccine to the parent and 
administered the vaccine if the parent requested it be given. 
The project director collected the pre- and posttests on a weekly basis until 20 sets were 
completed. The pre-test and post-test were paired with a de-identified number, placed on the tests 
prior to administration.  
Data Analysis 
The pre- and posttests were compared looking specifically for increase in knowledge of 
HPV prevalence, safety and efficacy of the HPV vaccine, and intent to vaccinate. For this study, 
attitudes about choosing or not choosing to vaccinate were not collected. Intent to vaccinate was 
evaluated in the project, but not the actual number of parents that consented to vaccination on the 
day the surveys were administered.  
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Results 
The project was completed between June 11, 2018, through August 1, 2018. Most of the 
surveys (n = 15, 75%) were completed by mothers, with the remainder of the surveys (n = 5, 
25%) were completed by fathers. The parents were all between the ages of 20 and 60 years, with 
half between the ages of 31-40 years (n = 10). See Table 1 for demographic information about 
the sample. 
Table 1 
Demographics of Sample 
n 
Gender 
 Male 5 
 Female 15 
Age 
20-30 years old 1 
31-40 years old 10 
41-50 years old 4 
51-60 years old 4 
 Over 60 years old 1 
The results of the pretest indicated half of the parents believed HPV to be the most 
common sexually transmitted infection while the other 50% did not believe it was the most 
common infection. The majority of parents (n = 16, 80%) did feel it was a safe vaccine, however 
four parents did not believe the vaccine to be safe and effective (20%). The final question of the 
pretest also indicated that most parents were planning on vaccinating their children against HPV 
(n = 16, 80%), with four parents choosing not to vaccinate (20%).  
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The posttest results demonstrated slightly more parents (n = 12, 60%) believed that HPV 
was the most common sexually transmitted infection after the educational intervention. Four 
parents (20%) continued to believe it was not the most common. Regarding the safety of the 
HPV vaccine, 18 parents thought the vaccine was safe on the posttest (90%) with two parents not 
believing the vaccine was safe (10%). Finally, 18 (90%) of the parents were planning on giving 
the HPV immunization to their children after the educational intervention and two (10%) parents 
continued to indicate they would not vaccinate their child against HPV. See Table 2 for results of 
pretest and posttest responses. 
Table 2 
Pretest and Posttest Comparisons 
Pretest Posttest Change 
n n 
(%) 
Question 1: 1. Do you think the genital wart 
virus, HPV, is the most common infection 
caused by sexual contact? 
 Yes 10 12 20 
 No 10 8 - 20
Question 2: 1. Do you think the HPV vaccine 
(shot) is safe for your child and works well? 
 Yes 16 18 12.5 
 No 4 2 - 50
Question 3: 1. Do you plan on vaccinating your 
child against HPV? 
 Yes 16 18 12.5 
 No 4 2 - 50
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Comments on the open-ended posttest response requesting why the parent was not 
vaccinating today and/or not vaccinating at all were also reviewed. Those comments included: 
“have received conflicting information about the safety of the vaccine”, “want to do more 
research on the vaccine before getting for my child”, “would like to see more longitudinal data 
about vaccine”, and “hasn’t been out long enough”.  
Conclusions 
The posttest indicated a modest increase (10%) in knowledge of HPV and belief in the 
safety of the vaccine after the educational information was presented to the parents. There was 
also a modest increase (10%) in intent to vaccinate after the intervention.  
The author anticipated a more robust increase in both knowledge and intent to vaccinate 
after the educational intervention by the RN. There are several possible conclusions from the 
survey results including population bias, ineffective educational intervention, and knowledge 
base of the parents surveyed. The population may be biased as they are presenting to the health 
department seeking vaccination(s) for their child. Therefore, no parents that are generally 
opposed to vaccinations were included in the study. The health department is located directly 
next to the largest group of health care providers in the county and much of that patient 
population receive vaccinations at the Franklin County Health Department. An assumption could 
be made that many of the parent(s) and child(ren) are receiving regular health care and are more 
apt to have had the HPV vaccination recommended to them by their health care provider. It is 
also possible that many of the parent(s) and child(ren) not receiving any or regular health care 
might not have been included in the convenience sample obtained.  
There are many outside influences that could have impacted the project, including the 
possibility that the parent was in a hurry to be done or perhaps distracted by events of the day. 
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Another possibility would be that the parent had already set views on HPV and the HPV 
vaccination and were not open to receiving new information. 
In analyzing the pretest, it appears the convenience sample had knowledge of HPV and 
the vaccination prior to the intervention and were also planning on their child receiving the HPV 
immunization. In the convenience sample obtained, sixteen of the twenty parents surveyed felt 
the vaccine was safe and were planning on vaccinating their child. This impacted the project as 
there were fewer parents to expose to new and(or)correct information during the educational 
intervention. 
An area that needs more educational intervention was general knowledge about HPV, 
including the incidence and prevalence of the disease. In the pretest, only half of those surveyed 
thought that HPV was the most common sexually transmitted infection. After the intervention, 
there was a slight change in the results with twelve parents (60%) acknowledging HPV as the 
most common STI, and eight parents still not recognizing this.  
Discussion 
After completing the project, the author found many of the conclusions in the literature to 
be consistent with this study. The project identified a need for more education regarding HPV 
infection, particularly incidence and prevalence. Most of the sample for the project believed in 
the safety and efficacy of the vaccine which contrasted with the literature where many parents 
were unsure of the safety and efficacy of the vaccine. The author was pleased with the number of 
parents that intended to vaccinate against HPV, but at the same time was also confused 
considering a smaller number of parents surveyed believed HPV was the most prevalent STI. 
The author anticipated more resistance for the vaccine due to beliefs the vaccine would promote 
sexual behavior and belief regarding the safety and efficacy of the vaccine.  
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The author has several recommendations after completing the educational intervention 
and comparing the pre-and posttest performance. The first recommendation would be to access 
parents in a different setting such as “Back to School” nights or pre-registration at the local 
schools. This access point would possibly capture the population needing the educational 
intervention. The pilot study for the educational intervention did not capture many of those 
parents that were questioning the safety, efficacy, and importance of the HPV vaccination.  
  Another recommendation would be to change the educational intervention to make it 
more interactive with both the parent and the child. Engaging both participants is important for 
the parent and child to buy into the message given. 
  The educational intervention did have a positive outcome, though not as dramatic as 
anticipated. With a few modifications, the intervention could be incorporated in the surrounding 
county health departments with very minimal expenditure of cost or time.  
Implications for Practice 
The need for continued, ongoing education of health care providers, staff, parents and 
teens regarding all aspects of HPV and the HPV vaccine is important for practice. The review of 
the literature for this project identified a need to explore the educational needs and methods 
among a variety of community settings and among a variety of ethnic groups. One specific 
educational intervention did not stand out as best, thus recognizing the diversity of the general 
population that may require a variety of educational styles and interventions.      
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20-30 years old_____ 41-50 years old_____  Over 60 years old_____ 
31-40 years old_____ 51-60 years old_____




2. Do you think the HPV vaccine (shot) is safe for your child and works well?
Yes_____
No______











2. Do you think the HPV vaccine (shot) is safe for your child and works well? 
Yes_____ 
No______ 
3. Do you plan on vaccinating your child against HPV? 
Yes_____ 
No______ 
If you do not plan on vaccinating your child, please tell us why. If you plan on vaccinating your 
child against HPV later, please let us know why you are not vaccinating today.   
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Appendix C 
Letter to Participants 
Dear Participant, 
My name is Patricia West, APRN. I am currently working on my Doctorate of Nursing Practice 
(DNP) at the University of Kansas. I am working very closely with Dr. Cara Busenhart 
(cbusenhart@kumc.edu) and Dr. Karen Trees (ktrees@kumc.edu) in order to complete my DNP 
project. You are being asked to take part in the study because you have a child between the ages 
of 9-17. The main purpose of the study is to create new knowledge for the benefit of future 
patients and society in general regarding the human papillomavirus (HPV) and the HPV vaccine. 
 
Your participation will involve completing a pre- and post-educational questionnaire type 
survey. This survey will be administered, followed by a short educational intervention 
highlighting the key points from an educational brochure presented by a registered nurse at the 
FCHD. Following the educational services, you will be provided with a post-educational survey 
and then offered the vaccine. The responses to the surveys are not timed. All FCHD English 
speaking clients who have children seeking vaccination between the ages of 9 and 17 and do not 
require a surrogate or interpreter are eligible to participate. Once the study is completed the data 
will be compiled and interpreted for future recommendations. You can ask questions at any time 
during the study. The researchers will tell you if they receive any new information that might 
cause you to change your mind about participating. 
 
The research study will take place at the Franklin County Health Department with Patricia West, 
APRN as the researcher. Approximately 20 plus people will be participating in the study which 
will take about 15 minutes of your time to complete. 
 
I thank you in advance for your participation. 
 
Sincerely, 
Patricia West, APRN 
 
 
Signature of Participant                                                                        Date & Time 
 
 











HPV Vaccine for Preteens and Teens 
HPV vaccination is recommended at ages 11-12 to protect against cancers caused by HPV infection. 
Why does my child need HPV vaccine?  
When should my child be vaccinated?  
Human papillomavirus (HPV) vaccine protects against cancers caused by HPV infection. 
HPV is a common virus that infects teens and adults. About 14 million people, including teens, become infected with HPV each 
year. HPV infection can cause cervical, vaginal, and vulvar cancers in women and penile cancer in men. HPV can also cause anal 
cancer, cancer of the back of the throat (oropharynx), and genital warts in both men and women.  
All kids who are 11 or 12 years old should get two shots of HPV vaccine six to twelve months apart. Getting vaccinated on 
time protects preteens long before ever being exposed to the virus. People get HPV from another person during intimate sexual 
contact.  
Some children may need three doses of HPV vaccine. For example, adolescents who receive their two shots less than five months 
apart will need a third dose for best protection. Also, children who start the vaccine series on or after their 15th birthday need 
three shots given over 6 months. If your teen hasn’t gotten the vaccine yet, talk to his/her doctor about getting it as soon as 
possible.  
The best way to remember to get your child all of the recommended doses is to make an appointment for the remaining shots 
before you leave the doctor’s office or clinic.  
HPV vaccination provides safe, effective, and long-lasting protection against cancers caused by HPV. HPV vaccine has a 
reassuring safety record that’s backed by 10 years of monitoring and research.  
Like any vaccine or medicine, HPV vaccination can cause side effects. The most common side effects are mild and include pain, 
redness, or swelling in the arm where the shot was given; dizziness, fainting, nausea, and headache. Fainting after any vaccine, 
including HPV vaccine, is more common among adolescents.  
To prevent fainting and injuries related to fainting, adolescents should be seated or lying down during vaccination and remain in 
that position for 15 minutes after the vaccine is given. The benefits of HPV vaccination far outweigh any potential risk of side 
effects.  
It is important to tell the doctor or nurse if your child has any severe allergies, including an allergy to latex or yeast. HPV vaccine 
is not recommended for anyone who is pregnant.  
The Vaccines for Children (VFC) program provides vaccines for children ages 18 years and younger, who are uninsured, 
Medicaid-eligible, American Indian or Alaska Native. 
Learn more at www.cdc.gov/Features/VFCprogram  
Is HPV vaccine safe for my child?  
How can I get help paying for these vaccines? 
Where can I learn more? 
Talk to your child’s doctor or nurse to learn more about HPV vaccine and the other vaccines that your child may need. You can 
also find out more about HPV vaccine at http/www.cdc.gov/hp
